At site of bone resorption (Figure 8), the activation by Ca2+ of the CaSR expressed by metastatic breast cancer cells favors epiregulin synthesis and secretion, which in turn acts on osteoblastic cells to reduce OPG synthesis. The gene discussed is CASR; the disease is breast cancer.